Advance in oral delivery of living material

[1]  Ronnie H. Fang,et al.  Gastrointestinal tract drug delivery using algae motors embedded in a degradable capsule , 2022, Sci. Robotics.

[2]  J. Guzowski,et al.  Microfluidic Formulation of Topological Hydrogels for Microtissue Engineering , 2022, Chemical reviews.

[3]  Hyomin K. Lee,et al.  Oral delivery of stem-cell-loaded hydrogel microcapsules restores gut inflammation and microbiota. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Neel S. Joshi,et al.  A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea , 2022, Nature Communications.

[5]  Xingcai Zhang,et al.  Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy , 2022, Nature Communications.

[6]  T. Lu,et al.  Engineered Living Hydrogels , 2022, Advanced materials.

[7]  F. Strati,et al.  Microbiota-targeted therapies in inflammation resolution. , 2022, Seminars in immunology.

[8]  A. del Campo,et al.  Regulating Bacterial Behavior within Hydrogels of Tunable Viscoelasticity , 2022, bioRxiv.

[9]  E. Pamer,et al.  Microbiome-based therapeutics , 2022, Nature Reviews Microbiology.

[10]  W. Cui,et al.  Nutrient capsules maintain tear film homeostasis for human corneal lenticule transplantation , 2022, Chemical Engineering Journal.

[11]  Yan Ding,et al.  RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery , 2021, Journal of Controlled Release.

[12]  G. Traverso,et al.  Foundations of gastrointestinal-based drug delivery and future developments , 2021, Nature Reviews Gastroenterology & Hepatology.

[13]  H. Moon,et al.  Exfoliated bentonite/alginate nanocomposite hydrogel enhances intestinal delivery of probiotics by resistance to gastric pH and on-demand disintegration. , 2021, Carbohydrate polymers.

[14]  M. Marzorati,et al.  Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system. , 2021, Food research international.

[15]  Yuanjin Zhao,et al.  Roe-inspired stem cell microcapsules for inflammatory bowel disease treatment , 2021, Proceedings of the National Academy of Sciences.

[16]  Qi-wen Chen,et al.  Customized materials-assisted microorganisms in tumor therapeutics. , 2021, Chemical Society reviews.

[17]  Nathan Crook,et al.  Discovery and delivery strategies for engineered live biotherapeutic products. , 2021, Trends in biotechnology.

[18]  Quanyin Hu,et al.  Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy , 2021, Advanced materials.

[19]  M. Dimian,et al.  Applications of Biopolymers for Drugs and Probiotics Delivery , 2021, Polymers.

[20]  L. Deng,et al.  Colon‐Targeted Adhesive Hydrogel Microsphere for Regulation of Gut Immunity and Flora , 2021, Advanced science.

[21]  L. Qin,et al.  Recent Advances in Microfluidic Platforms for Programming Cell‐Based Living Materials , 2021, Advanced materials.

[22]  R. Mrsny,et al.  Evaluating parameters affecting drug fate at the intramuscular injection site. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Anders B. Dohlman,et al.  Living fabrication of functional semi-interpenetrating polymeric materials , 2021, Nature Communications.

[24]  M. Yen,et al.  Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells , 2021, Stem cells translational medicine.

[25]  L. Deng,et al.  Capturing dynamic biological signals via bio-mimicking hydrogel for precise remodeling of soft tissue , 2021, Bioactive materials.

[26]  Subhajit Mukherjee,et al.  Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches , 2021, Science Advances.

[27]  S. Caridade,et al.  Sublingual protein delivery by a mucoadhesive patch made of natural polymers. , 2021, Acta biomaterialia.

[28]  N. Joshi,et al.  Robust Self‐Regeneratable Stiff Living Materials Fabricated from Microbial Cells , 2021, Advanced functional materials.

[29]  John R. Clegg,et al.  Cell therapies in the clinic , 2021, Bioengineering & translational medicine.

[30]  Jinyao Liu,et al.  Polymerization‐Mediated Multifunctionalization of Living Cells for Enhanced Cell‐Based Therapy , 2021, Advanced materials.

[31]  Danni Zhong,et al.  Algae: A natural active material for biomedical applications , 2021, View.

[32]  I. Kassem,et al.  Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection , 2020, Gut microbes.

[33]  Yitao Wang,et al.  Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies , 2020, Acta pharmaceutica Sinica. B.

[34]  Xin-tong Zhang,et al.  The influence of the gut microbiota on the bioavailability of oral drugs , 2020, Acta pharmaceutica Sinica. B.

[35]  Luoran Shang,et al.  Living Materials for Regenerative Medicine , 2021, Engineered Regeneration.

[36]  Hui Tan,et al.  Oral biomaterials for intestinal regulation , 2021, Engineered Regeneration.

[37]  Yuanjin Zhao,et al.  Living Materials for Life Healthcare , 2020 .

[38]  C. Hill,et al.  Gut Colonization Mechanisms of Lactobacillus and Bifidobacterium: An Argument for Personalized Designs. , 2020, Annual review of food science and technology.

[39]  D. Kelly,et al.  Designing bugs as drugs: exploiting the gut microbiome. , 2020, American journal of physiology. Gastrointestinal and liver physiology.

[40]  W. Cui,et al.  ECM-inspired micro/nanofibers for modulating cell function and tissue generation , 2020, Science Advances.

[41]  H. Feng,et al.  A probiotic yeast-based immunotherapy against Clostridioides difficile infection , 2020, Science Translational Medicine.

[42]  Danni Zhong,et al.  Biomineralized Biohybrid-Algae for Tumor Hypoxia Modulation and Cascade Radio-Photodynamic Therapy. , 2020, ACS applied materials & interfaces.

[43]  Patrice D Cani,et al.  Mucus barrier, mucins and gut microbiota: the expected slimy partners? , 2020, Gut.

[44]  O. Pedersen,et al.  Gut microbiota in human metabolic health and disease , 2020, Nature Reviews Microbiology.

[45]  B. Pot,et al.  Live biotherapeutic products: the importance of a defined regulatory framework , 2020, Experimental & Molecular Medicine.

[46]  B. Kong,et al.  Dual-core Prebiotics Microcapsule Encapsulating Probiotics for Metabolic Syndrome. , 2020, ACS applied materials & interfaces.

[47]  O. Farokhzad,et al.  Oral insulin delivery platforms: Strategies to address the biological barriers. , 2020, Angewandte Chemie.

[48]  Jinyao Liu,et al.  On‐Demand Bacterial Reactivation by Restraining within a Triggerable Nanocoating , 2020, Advanced materials.

[49]  G. Michailidis,et al.  Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice , 2020, Science Translational Medicine.

[50]  M. Zhang,et al.  Improved Gastric Acid Resistance and Adhesive Colonization of Probiotics by Mucoadhesive and Intestinal Targeted Konjac Glucomannan Microspheres , 2020, Advanced Functional Materials.

[51]  Annika Lundqvist,et al.  The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study. , 2020, Cell metabolism.

[52]  Metin Sitti,et al.  High‐Yield Production of Biohybrid Microalgae for On‐Demand Cargo Delivery , 2020, Advanced science.

[53]  Jinyao Liu,et al.  Bioinspired oral delivery of gut microbiota by self-coating with biofilms , 2020, Science Advances.

[54]  S. Ermakova,et al.  Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine , 2020, Marine drugs.

[55]  Jacob W. Coffey,et al.  Oral Biologic Delivery: Advances Towards Oral Subunit, DNA and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics. , 2020, Annual review of pharmacology and toxicology.

[56]  H. Xiong,et al.  Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation , 2020, Journal of digestive diseases.

[57]  Ava M Vargason,et al.  Surface Modifications for Improved Delivery and Function of Therapeutic Bacteria. , 2020, Small.

[58]  Yi Sun,et al.  Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer , 2020, Science Advances.

[59]  Jinhui Wu,et al.  Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetes , 2020, Science Advances.

[60]  Nikhil U. Nair,et al.  Engineered lactobacilli display anti-biofilm and growth suppressing activities against Pseudomonas aeruginosa , 2020, bioRxiv.

[61]  V. Préat,et al.  Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[62]  I. Choi,et al.  Single‐Cell Nanoencapsulation: From Passive to Active Shells , 2020, Advanced materials.

[63]  E. Elinav,et al.  Immune-Microbiota Interplay and Colonization Resistance in Infection. , 2020, Molecular cell.

[64]  Xin Wu,et al.  Probiotic Supplements: Hope or Hype? , 2020, Frontiers in Microbiology.

[65]  Fangdi Hu,et al.  The metabolic effect of gut microbiota on drugs , 2020, Drug metabolism reviews.

[66]  Yan Zhao,et al.  Identifying psychiatric disorder-associated gut microbiota using microbiota-related gene set enrichment analysis , 2019, Briefings Bioinform..

[67]  Yongmin Yan,et al.  Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect , 2019, Clinical and Translational Medicine.

[68]  Jinyao Liu,et al.  Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment , 2019, Nature Communications.

[69]  G. Canonica,et al.  30 years of sublingual immunotherapy , 2019, Allergy.

[70]  J. Burdick,et al.  Hydrogel microparticles for biomedical applications , 2019, Nature Reviews Materials.

[71]  Huafeng Tian,et al.  Encapsulation of Lactobacillus plantarum in cellulose based microgel with controlled release behavior and increased long-term storage stability. , 2019, Carbohydrate polymers.

[72]  Miriam H. Huntley,et al.  Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. , 2019, The New England journal of medicine.

[73]  M. Blaser.  Fecal Microbiota Transplantation for Dysbiosis - Predictable Risks. , 2019, The New England journal of medicine.

[74]  Wei Tang,et al.  Challenges and advances in stem cell therapy. , 2019, Bioscience trends.

[75]  I. Mook‐Jung,et al.  Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model , 2019, Gut.

[76]  Neel S. Joshi,et al.  Genetically Programmable Self‐Regenerating Bacterial Hydrogels , 2019, Advanced materials.

[77]  G. Reid,et al.  Probiotics and prebiotics in intestinal health and disease: from biology to the clinic , 2019, Nature Reviews Gastroenterology & Hepatology.

[78]  M. Alonso,et al.  Oral Delivery of Biologics for Precision Medicine , 2019, Advanced materials.

[79]  Hong Xia,et al.  Precise Construction of Cell-Instructive 3D Microenvironments by Photopatterning a Biodegradable Hydrogel , 2019, Chemistry of Materials.

[80]  M. Maus,et al.  Gene editing for immune cell therapies , 2019, Nature Biotechnology.

[81]  E. Segal,et al.  The pros, cons, and many unknowns of probiotics , 2019, Nature Medicine.

[82]  C. Andrade.  Oral Ketamine for Depression, 1: Pharmacologic Considerations and Clinical Evidence. , 2019, The Journal of clinical psychiatry.

[83]  Jianzhong Fu,et al.  Bioprinting of Cell‐Laden Microfiber: Can It Become a Standard Product? , 2019, Advanced healthcare materials.

[84]  B. Weigmann,et al.  Advances in orally‐delivered pH‐sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease , 2019, International journal of pharmaceutics.

[85]  P. Levkin,et al.  Design and Applications of Photoresponsive Hydrogels , 2019, Advanced materials.

[86]  Hyo-Jick Choi,et al.  Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals , 2019, Pharmaceutics.

[87]  Ronald X. Xu,et al.  Gas‐Shearing Fabrication of Multicompartmental Microspheres: A One‐Step and Oil‐Free Approach , 2019, Advanced science.

[88]  Robert Langer,et al.  An ingestible self-orienting system for oral delivery of macromolecules , 2019, Science.

[89]  Deyuan Zhang,et al.  Facile Fabrication of Magnetic Microrobots Based on Spirulina Templates for Targeted Delivery and Synergistic Chemo-Photothermal Therapy. , 2019, ACS applied materials & interfaces.

[90]  B. Ryan,et al.  The future of nanomedicine in optimising the treatment of inflammatory bowel disease , 2019, Scandinavian journal of gastroenterology.

[91]  Luoran Shang,et al.  Design of capillary microfluidics for spinning cell-laden microfibers , 2018, Nature Protocols.

[92]  Metin Sitti,et al.  Microalga‐Powered Microswimmers toward Active Cargo Delivery , 2018, Advanced materials.

[93]  Jae Young Lee,et al.  Hydrogel Biomaterials for Stem Cell Microencapsulation , 2018, Polymers.

[94]  J. Karp,et al.  Therapeutic luminal coating of the intestine , 2018, Nature Materials.

[95]  Neel S. Joshi,et al.  Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials , 2018, Advanced materials.

[96]  Pamela A. Silver,et al.  Engineering bacteria for diagnostic and therapeutic applications , 2018, Nature Reviews Microbiology.

[97]  J. Suez,et al.  Sieving through gut models of colonization resistance , 2018, Nature Microbiology.

[98]  C. Ehrhardt,et al.  Inhalation delivery of complex drugs — the next steps , 2017, Current opinion in pharmacology.

[99]  L. Albenberg,et al.  Gut microbiota and IBD: causation or correlation? , 2017, Nature Reviews Gastroenterology &Hepatology.

[100]  Chia-Hung Chen,et al.  Heterogeneous multi-compartmental hydrogel particles as synthetic cells for incompatible tandem reactions , 2017, Nature Communications.

[101]  Yuanjin Zhao,et al.  Microfluidic generation of Buddha beads-like microcarriers for cell culture , 2017, Science China Materials.

[102]  Fangfang Guo,et al.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.

[103]  Arjun Gupta,et al.  Fecal Microbiota Transplantation. , 2017, JAMA.

[104]  Huijue Jia,et al.  Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention , 2017, Nature Medicine.

[105]  Michael J Paulsen,et al.  An innovative biologic system for photon-powered myocardium in the ischemic heart , 2017, Science Advances.

[106]  J. Collier,et al.  Biomaterial strategies for generating therapeutic immune responses , 2017, Advanced drug delivery reviews.

[107]  Ali Khademhosseini,et al.  Advances in engineering hydrogels , 2017, Science.

[108]  C. Hill,et al.  Next-generation probiotics: the spectrum from probiotics to live biotherapeutics , 2017, Nature Microbiology.

[109]  Xiaocen Dou,et al.  Amino Acids and Peptide‐Based Supramolecular Hydrogels for Three‐Dimensional Cell Culture , 2017, Advanced materials.

[110]  Soumen Roy,et al.  Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.

[111]  R. Caillard,et al.  In vitro gastric survival of commercially available probiotic strains and oral dosage forms. , 2017, International journal of pharmaceutics.

[112]  S. Dowd,et al.  Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers , 2016, Gut microbes.

[113]  J. Arrieta,et al.  Phototaxis beyond turning: persistent accumulation and response acclimation of the microalga Chlamydomonas reinhardtii , 2016, Scientific Reports.

[114]  S. Lynch,et al.  The Human Intestinal Microbiome in Health and Disease. , 2016, The New England journal of medicine.

[115]  Robert Langer,et al.  Layer‐by‐Layer Encapsulation of Probiotics for Delivery to the Microbiome , 2016, Advanced materials.

[116]  Benjamin M Hillmann,et al.  Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome. , 2016, Cell host & microbe.

[117]  M. Ferrante,et al.  Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial , 2016, The Lancet.

[118]  A. Shields,et al.  Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature , 2016, Patient preference and adherence.

[119]  S. Kugathasan,et al.  The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses , 2016, Alimentary pharmacology & therapeutics.

[120]  K. Kuča,et al.  The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview , 2016, Archives of Toxicology.

[121]  S. Raghavan,et al.  Chitosan–Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM‐1‐Targeting Nanocarriers, Enabling GI Targeting In Vivo , 2016, Advanced functional materials.

[122]  Ali Khademhosseini,et al.  Textile Technologies and Tissue Engineering: A Path Toward Organ Weaving , 2016, Advanced healthcare materials.

[123]  C. Dekker,et al.  Nanofabricated structures and microfluidic devices for bacteria: from techniques to biology. , 2016, Chemical Society reviews.

[124]  Zhongze Gu,et al.  Controlled Fabrication of Bioactive Microfibers for Creating Tissue Constructs Using Microfluidic Techniques. , 2016, ACS applied materials & interfaces.

[125]  C. Mbofung,et al.  Impact of daily supplementation of Spirulina platensis on the immune system of naïve HIV-1 patients in Cameroon: a 12-months single blind, randomized, multicenter trial , 2015, Nutrition Journal.

[126]  Meng Chen,et al.  The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection , 2015, Patient preference and adherence.

[127]  Susan Hua,et al.  Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[128]  J. Beniak,et al.  Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. , 2015, Complementary therapies in medicine.

[129]  Md. Faruk Hossain,et al.  Effect of Spirulina Intervention on Oxidative Stress, Antioxidant Status, and Lipid Profile in Chronic Obstructive Pulmonary Disease Patients , 2015, BioMed research international.

[130]  Ji Hun Park,et al.  A cytoprotective and degradable metal-polyphenol nanoshell for single-cell encapsulation. , 2014, Angewandte Chemie.

[131]  Madhu Gupta,et al.  Is nanotechnology a boon for oral drug delivery? , 2014, Drug discovery today.

[132]  C. Tuleu,et al.  Rectal route in the 21st Century to treat children. , 2014, Advanced drug delivery reviews.

[133]  S. Nuding,et al.  Intestinal barrier in inflammatory bowel disease. , 2014, World journal of gastroenterology.

[134]  J. Majoral,et al.  Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. , 2013, Advanced drug delivery reviews.

[135]  W. Rosas-Flores,et al.  Microencapsulation of Lactobacillus helveticus and Lactobacillus delbrueckii using alginate and gellan gum. , 2013, Carbohydrate polymers.

[136]  E H Murchie,et al.  Chlorophyll fluorescence analysis: a guide to good practice and understanding some new applications. , 2013, Journal of experimental botany.

[137]  M. Meyerson,et al.  Microbes and Inflammation in Colorectal Cancer , 2013, Cancer Immunology Research.

[138]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[139]  Cui Tang,et al.  Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages. , 2013, Biomaterials.

[140]  Wendell A. Lim,et al.  Cell-Based Therapeutics: The Next Pillar of Medicine , 2013, Science Translational Medicine.

[141]  R. Bjerkvig,et al.  Mesenchymal stem cell signaling in cancer progression. , 2013, Cancer treatment reviews.

[142]  R. Webby,et al.  Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study , 2013, The Lancet. Infectious diseases.

[143]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[144]  Y. Lvov,et al.  "Face-lifting" and "make-up" for microorganisms: layer-by-layer polyelectrolyte nanocoating. , 2012, ACS nano.

[145]  V. N. Paunov,et al.  Cyborg cells: functionalisation of living cells with polymers and nanomaterials. , 2012, Chemical Society reviews.

[146]  Laura M Ensign,et al.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.

[147]  Jiandi Wan,et al.  Microfluidic-Based Synthesis of Hydrogel Particles for Cell Microencapsulation and Cell-Based Drug Delivery , 2012 .

[148]  A. Tiwari,et al.  Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon , 2012 .

[149]  V. Maheshwari,et al.  Graphene as membrane for encapsulation of yeast cells: protective and electrically conducting. , 2011, Chemical communications.

[150]  I. Choi,et al.  Bioinspired functionalization of silica-encapsulated yeast cells. , 2011, Angewandte Chemie.

[151]  Matthew R. Redinbo,et al.  Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.

[152]  R. Wijffels,et al.  An Outlook on Microalgal Biofuels , 2010, Science.

[153]  Wendell A. Lim,et al.  Designing customized cell signalling circuits , 2010, Nature Reviews Molecular Cell Biology.

[154]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[155]  I. Choi,et al.  Biomimetic encapsulation of individual cells with silica. , 2009, Angewandte Chemie.

[156]  T. Vandamme,et al.  Microencapsulation of Lactobacillus plantarum spp in an alginate matrix coated with whey proteins. , 2009, International journal of food microbiology.

[157]  Yusuke Inoue,et al.  Comparison of subcutaneous and intraperitoneal injection of d-luciferin for in vivo bioluminescence imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[158]  M. Schenk,et al.  The mucosal immune system at the gastrointestinal barrier. , 2008, Best practice & research. Clinical gastroenterology.

[159]  P. Liu,et al.  Yeast cells with an artificial mineral shell: protection and modification of living cells by biomimetic mineralization. , 2008, Angewandte Chemie.

[160]  Haeshin Lee,et al.  Mussel-Inspired Surface Chemistry for Multifunctional Coatings , 2007, Science.

[161]  F. Manguso,et al.  Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations , 2007, BMJ : British Medical Journal.

[162]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[163]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[164]  M. Subirade,et al.  Protection of bifidobacteria encapsulated in polysaccharide-protein gel beads against gastric juice and bile. , 2003, Journal of food protection.

[165]  M. Griffiths,et al.  Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads. , 2000, International journal of food microbiology.

[166]  W. Zempsky.  Alternative Routes of Drug Administration— Advantages and Disadvantages (Subject Review) , 1998, Pediatrics.

[167]  G. Witman.  Chlamydomonas phototaxis. , 1993, Trends in cell biology.

[168]  S. S. Davis,et al.  The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations , 1985, The Journal of pharmacy and pharmacology.